Srpski

English

العربية

Deutsch

Français

Italiano

Español

Ελληνικά

Türkçe

Srpski

中文
+381 64 251 88 20
+381 64 251 88 20
erdeljan@viderma.co.rs
Top tretmani Tretman Autizma Anti-Aging tretman Tretman srca Tretman diabetesa Tretman multipla skleroze Tretman mišićne distrofije ALS/MND Alchajmerova bolest Anemija Arterijska hipertenzija Kancer Cerebralna paraliza Usporen psih.mot.razvoj Erektivna disfunkcija Parkinsonova bolest Reumatoidni artritis SMA Ulcerativni kolitis. Kronova bolest Male Infertility
Top tretmani Tretman Autizma Anti-Aging tretman Tretman srca Tretman diabetesa Tretman multipla skleroze Tretman mišićne distrofije
See All
ALS/MND Alchajmerova bolest Anemija Arterijska hipertenzija Kancer Cerebralna paraliza Usporen psih.mot.razvoj Erektivna disfunkcija Parkinsonova bolest Reumatoidni artritis SMA Ulcerativni kolitis. Kronova bolest Male Infertility
Hide

Site Menu

Our licences

→
→

Feedback on J.M. condition after stem cell therapy

Patient: J.M.
Gender: Male
Age: 10
Country: USA
Diagnosis: Autism spectrum disorder 
Dates of treatment: August 19-20, 2013

Hi,

J.'s speech has not increased much, but he no longer displays aggressive behavior which has been a huge relief.  This week we got a telephone call from J.'s school counselor just to tell us that they are very happy with J.'s progress and that he seems happy.  

Thank you.

Rezultat tretmana fetalnim matičnim ćelijama zavisi od: težine bolesti, starosne dobi pacijenta, doslednosti i privrženosti medikaciji i režimu. Rezultati tretmana, prezentovani na ovom sajtu, su individualni za svaki klinički slučaj.
Naši kontakti

Viderma d.o.o.

E-mail adresa: erdeljan@viderma.co.rs

Naša adresa:

Gagarinova 10/G​, 21000 ​ ​Novi Sad, ​ ​Serbia​

Fiksni:

+381 21 443 3 84

Fax:

+381 21 477 0 239

Mobilni:

+381 64 251 88 20
wechat
English
© 1999-2020 EmCell.com